Table 3.
Clinical features | Survivors (n = 93) | Non survivors (n = 96) | p value |
---|---|---|---|
Demographic factors |
|
|
|
Mean age |
59.3 ± 18.6 |
61.0 ±17.4 |
0.52 |
≥ 65 years age |
48 (52%) |
52 (54%) |
0.73 |
Gender male/female |
55/38 |
55/41 |
0.79 |
ATS major criteria |
|
|
|
Use of mechanical ventilation |
18 (19%) |
29 (30%) |
0.08 |
Septic shock |
23 (25%) |
59 (61%) |
< 0.001 |
History |
|
|
|
Prior antibiotic use |
14 (15%) |
26 (27%) |
0.04 |
Comorbids |
76 (82%) |
84 (88%) |
0.27 |
Physical examination findings |
|
||
Blood pressure ≤ 90/60 mmHg |
25 (27%) |
30 (31%) |
0.51 |
Pulse ≥ 120/min |
32 (34%) |
37 (39%) |
0.55 |
Respiratory Rate 30/min |
56 (60%) |
57 (59%) |
0.95 |
Laboratory findings |
|
|
|
Blood urea nitrogen ≥ 30 mg/dl |
44 (47%) |
59 (61%) |
0.03 |
Creatinine > 1.5 mg/dL |
48 (52%) |
53 (55%) |
0.25 |
Hematocrit <30% |
22 (24%) |
37 (39%) |
0.03 |
Na <130 mmol/L |
22 (24%) |
28 (29%) |
0.39 |
Arterial pH <7.35 |
28 (30%) |
32 (33%) |
0.63 |
Radiographic findings |
|
|
|
Pleural effusion |
32 (34%) |
38 (40%) |
0.46 |
Bilateral involvement |
36 (39%) |
53 (55%) |
0.07 |
Multilobar involvement |
28 (30%) |
38 (40%) |
0.22 |
Mean APACHE II score |
19.1 ±6.0 |
28.2 ±7.0 |
<0.001 |
APACHE II score ≥ 20 | 38 (41%) | 80 (83.0%) | <0.001 |